請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90407完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 賴裕和 | zh_TW |
| dc.contributor.advisor | Yeur-Hur Lai | en |
| dc.contributor.author | 何汶峯 | zh_TW |
| dc.contributor.author | Man-Fong Ho | en |
| dc.date.accessioned | 2023-09-28T16:15:31Z | - |
| dc.date.available | 2025-08-08 | - |
| dc.date.copyright | 2023-09-28 | - |
| dc.date.issued | 2023 | - |
| dc.date.submitted | 2023-08-09 | - |
| dc.identifier.citation | 王敏家、鄭哲舟、黃文聰、張書展、李淞維(2014)．攝護腺癌病人勃起功能對生活品質之影響 [Association of Erectile Function of Quality of Life of Prostate Cancer Patients]．護理暨健康照護研究，10(1)，51-60。 https://doi.org/10.6225/jnhr.10.1.51
黃昭淵(2015)．攝護腺癌病人的生活建議 [Lifestyle Recommendations for Prostate Cancer Patients]．台灣醫學，19(6)，609-613。 https://doi.org/10.6320/fjm.2015.19(6).07 黃柏仁、邱逸淳(2015)．攝護腺癌早期診斷指引：摘譯2014年美國泌尿科醫學會評論 [Early Detection of Prostate Cancer: Selective Translation of 2014 American Urological Association Update Series Review]．北市醫學雜誌， 12(3)，1-8。 https://doi.org/10.6200/tcmj.2015.12.3.01 臺灣泌尿科醫學會(2012)．臨床泌尿學．金名圖書。 https://books.google.com.tw/books?id=EwDglwEACAAJ 衛生福利部．(2023)．111年國人死因統計結果．https://www.mohw.gov.tw/dl-83733-80fb9ab8-ea2d-4e3e-ba06-f70f28aca036.html 衛生福利部．(2023)．109年癌症登記報告．https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=269&pid=16434 歐宴泉、王約翰、熊小澐、楊晨洸、程千里、楊啟瑞(2010)．Minimally Invasive Surgery for Localized Prostate Cancer [綜合評論—局限性攝護腺癌之微創手術治療]．台灣癌症醫學雜誌，26(4)，2-11。 https://doi.org/10.6323/JoCRP.2010.26.4.1 Baguley, B. J., Bolam, K. A., Wright, O. R. L., & Skinner, T. L. (2017). The Effect of Nutrition Therapy and Exercise on Cancer-Related Fatigue and Quality of Life in Men with Prostate Cancer: A Systematic Review. Nutrients, 9(9). https://doi.org/10.3390/nu9091003 Bailey, D. E., Jr., Wallace, M., Latini, D. M., Hegarty, J., Carroll, P. R., Klein, E. A., & Albertsen, P. C. (2011). Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res, 24(4), 193-199. https://doi.org/10.1016/j.apnr.2009.08.001 Barry, M. J., Fowler, F. J., Jr., O'Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., & Cockett, A. T. (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol, 148(5), 1549-1557; discussion 1564. https://doi.org/10.1016/s0022-5347(17)36966-5 Bellardita, L., Rancati, T., Alvisi, M. F., Villani, D., Magnani, T., Marenghi, C., Nicolai, N., Procopio, G., Villa, S., Salvioni, R., & Valdagni, R. (2013). Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol, 64(1), 30-36. https://doi.org/10.1016/j.eururo.2013.01.009 Bellardita, L., Valdagni, R., van den Bergh, R., Randsdorp, H., Repetto, C., Venderbos, L. D., Lane, J. A., & Korfage, I. J. (2015). How does active surveillance for prostate cancer affect quality of life? A systematic review. Eur Urol, 67(4), 637-645. https://doi.org/10.1016/j.eururo.2014.10.028 Bergengren, O., Garmo, H., Bratt, O., Holmberg, L., Johansson, E., & Bill-Axelson, A. (2018). Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study. Eur Urol Oncol, 1(1), 37-45. https://doi.org/10.1016/j.euo.2018.02.003 Burnet, K. L., Parker, C., Dearnaley, D., Brewin, C. R., & Watson, M. (2007). Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int, 100(3), 540-543. https://doi.org/10.1111/j.1464-410X.2007.07009.x Buyyounouski, M. K., Choyke, P. L., McKenney, J. K., Sartor, O., Sandler, H. M., Amin, M. B., Kattan, M. W., & Lin, D. W. (2017). Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin, 67(3), 245-253. https://doi.org/10.3322/caac.21391 Carroll, P. H., & Mohler, J. L. (2018). NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection. J Natl Compr Canc Netw, 16(5s), 620-623. https://doi.org/10.6004/jnccn.2018.0036 Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., DeKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T., & Southwick, P. C. (1994). Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol, 151(5), 1283-1290. https://doi.org/10.1016/s0022-5347(17)35233-3 Cheah, W. L., Ling, N. C., & Chang, K. H. (2016). The supportive care needs for prostate cancer patients in Sarawak. Chin Clin Oncol, 5(1), 7. https://doi.org/10.3978/j.issn.2304-3865.2016.02.01 Chie, W. C., Yang, C. H., Hsu, C., & Yang, P. C. (2004). Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Qual Life Res, 13(1), 257-262. https://doi.org/10.1023/b:Qure.0000015295.74812.06 Coyle, C., Morgan, E., Drummond, F. J., Sharp, L., & Gavin, A. (2017). Do men regret prostate biopsy: Results from the PiCTure study. BMC Urology, 17(1), 11. https://doi.org/10.1186/s12894-016-0194-y Dillard, A. J., Scherer, L. D., Ubel, P. A., Alexander, S., & Fagerlin, A. (2017). Anxiety symptoms prior to a prostate cancer diagnosis: Associations with knowledge and openness to treatment. British Journal of Health Psychology, 22(1), 151-168. Dinkel, A., & Herschbach, P. (2018). Fear of Progression in Cancer Patients and Survivors. Recent Results Cancer Res, 210, 13-33. https://doi.org/10.1007/978-3-319-64310-6_2 Donovan, J. L., Hamdy, F. C., Lane, J. A., Mason, M., Metcalfe, C., Walsh, E., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., Lennon, T., Bradshaw, L., Cooper, D., Herbert, P., Howson, J., Jones, A., Lyons, N., Salter, E., Thompson, P., . . . Neal, D. E. (2016). Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med, 375(15), 1425-1437. https://doi.org/10.1056/NEJMoa1606221 Egger, S. J., Calopedos, R. J., O'Connell, D. L., Chambers, S. K., Woo, H. H., & Smith, D. P. (2018). Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer. Eur Urol, 73(6), 859-867. https://doi.org/10.1016/j.eururo.2017.08.013 Fayers, P., & Bottomley, A. (2002). Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer, 38 Suppl 4, S125-133. https://doi.org/10.1016/s0959-8049(01)00448-8 Fong, E. J., & Cheah, W. L. (2016). Unmet Supportive Care Needs among Breast Cancer Survivors of Community-Based Support Group in Kuching, Sarawak. Int J Breast Cancer, 2016, 7297813. https://doi.org/10.1155/2016/7297813 Girgis, A., Lambert, S., & Lecathelinais, C. (2011). The supportive care needs survey for partners and caregivers of cancer survivors: development and psychometric evaluation. Psychooncology, 20(4), 387-393. https://doi.org/10.1002/pon.1740 Girgis, A., Stojanovski, E., Boyes, A., King, M., & Lecathelinais, C. (2012). The next generation of the supportive care needs survey: a brief screening tool for administration in the clinical oncology setting. Psychooncology, 21(8), 827-835. https://doi.org/10.1002/pon.1973 Ha, J. Y., Kim, B. H., Park, C. H., & Kim, C. I. (2014). Early experience with active surveillance in low-risk prostate cancer treated. Korean J Urol, 55(3), 167-171. https://doi.org/10.4111/kju.2014.55.3.167 Haack, M., Kramer, S., Seidel, G., & Dierks, M. L. (2020). Quality of life and fear of disease progression are associated with aspects of health literacy in men with prostate cancer from Germany. Support Care Cancer, 28(5), 2283-2292. https://doi.org/10.1007/s00520-019-05052-0 Harrison, J. D., Young, J. M., Price, M. A., Butow, P. N., & Solomon, M. J. (2009). What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer, 17(8), 1117-1128. https://doi.org/10.1007/s00520-009-0615-5 Hawe, P. (1990). Evaluating health promotion : a health worker's guide / Penelope Hawe, Deirdre Degeling, Jane Hall ; with the assistance of Alison Brierley. MacLennan & Petty. Heidenreich, A., Bastian, P. J., Bellmunt, J., Bolla, M., Joniau, S., van der Kwast, T., Mason, M., Matveev, V., Wiegel, T., Zattoni, F., & Mottet, N. (2014). EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol, 65(1), 124-137. https://doi.org/10.1016/j.eururo.2013.09.046 Herschbach, P., Berg, P., Dankert, A., Duran, G., Engst-Hastreiter, U., Waadt, S., Keller, M., Ukat, R., & Henrich, G. (2005). Fear of progression in chronic diseases: Psychometric properties of the Fear of Progression Questionnaire. Journal of Psychosomatic Research, 58(6), 505-511. https://doi.org/https://doi.org/10.1016/j.jpsychores.2005.02.007 Herschbach, P., & Dinkel, A. (2014). Fear of progression. Recent Results Cancer Res, 197, 11-29. https://doi.org/10.1007/978-3-642-40187-9_2 Hinz, A., Mehnert, A., Ernst, J., Herschbach, P., & Schulte, T. (2015). Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12. Support Care Cancer, 23(6), 1579-1587. https://doi.org/10.1007/s00520-014-2516-5 Huang, C. C., Lien, H. H., Sung, Y. C., Liu, H. T., & Chie, W. C. (2007). Quality of life of patients with gastric cancer in Taiwan: validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22. Psychooncology, 16(10), 945-949. https://doi.org/10.1002/pon.1158 Jeldres, C., Cullen, J., Hurwitz, L. M., Wolff, E. M., Levie, K. E., Odem-Davis, K., Johnston, R. B., Pham, K. N., Rosner, I. L., Brand, T. C., L'Esperance, J. O., Sterbis, J. R., Etzioni, R., & Porter, C. R. (2015). Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy. Cancer, 121(14), 2465-2473. https://doi.org/10.1002/cncr.29370 Kang, D. W., Fairey, A. S., Boulé, N. G., Field, C. J., Wharton, S. A., & Courneya, K. S. (2022). A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance. J Urol, 207(4), 814-822. https://doi.org/10.1097/ju.0000000000002334 Kato, T., & Sugimoto, M. (2020). Quality of life in active surveillance for early prostate cancer. Int J Urol, 27(4), 296-306. https://doi.org/10.1111/iju.14202 King, A. J., Evans, M., Moore, T. H., Paterson, C., Sharp, D., Persad, R., & Huntley, A. L. (2015). Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. Eur J Cancer Care (Engl), 24(5), 618-634. https://doi.org/10.1111/ecc.12286 Klotz, L. (2013). Active surveillance: patient selection. Current Opinion in Urology, 23(3), 239-244. https://doi.org/10.1097/MOU.0b013e32835f8f6b Klotz, L. (2020). Active surveillance in intermediate-risk prostate cancer. BJU Int, 125(3), 346-354. https://doi.org/10.1111/bju.14935 Kobayashi, M., Nukui, A., & Kamai, T. (2017). Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy. Int J Clin Oncol, 22(1), 174-180. https://doi.org/10.1007/s10147-016-1038-1 Kwakkenbos, L., van den Hoogen, F. H., Custers, J., Prins, J., Vonk, M. C., van Lankveld, W. G., Becker, E. S., & van den Ende, C. H. (2012). Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis. Arthritis Care Res (Hoboken), 64(6), 930-934. https://doi.org/10.1002/acr.21618 Loeb, S., Curnyn, C., Fagerlin, A., Braithwaite, R. S., Schwartz, M. D., Lepor, H., Carter, H. B., Ciprut, S., & Sedlander, E. (2018). Informational needs during active surveillance for prostate cancer: A qualitative study. Patient Educ Couns, 101(2), 241-247. https://doi.org/10.1016/j.pec.2017.08.022 Mader, E. M., Li, H. H., Lyons, K. D., Morley, C. P., Formica, M. K., Perrapato, S. D., Irwin, B. H., Seigne, J. D., Hyams, E. S., Mosher, T., Hegel, M. T., & Stewart, T. M. (2017). Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty. BMC Urol, 17(1), 35. https://doi.org/10.1186/s12894-017-0225-3 Mahmood, M. A., Rehman, K. U., Khan, M. A., & Sultan, T. (2012). Translation, cross-cultural adaptation, and psychometric validation of the 5-item International Index of Erectile Function (IIEF-5) into Urdu. J Sex Med, 9(7), 1883-1886. https://doi.org/10.1111/j.1743-6109.2012.02714.x Maslow, A. H. (1943). A theory of human motivation. Psychological Review, 50(4), 370-396. https://doi.org/10.1037/h0054346 McIntosh, M., Opozda, M. J., Evans, H., Finlay, A., Galvão, D. A., Chambers, S. K., & Short, C. E. (2019). A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. Psychooncology, 28(12), 2307-2322. https://doi.org/10.1002/pon.5262 Mehnert, A., Herschbach, P., Berg, P., Henrich, G., & Koch, U. (2006). [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]. Z Psychosom Med Psychother, 52(3), 274-288. https://doi.org/10.13109/zptm.2006.52.3.274 (Progredienzangst bei Brustkrebspatientinnen--Validierung der Kurzform des Progredienzangstfragebogens PA-F-KF.) Moses, K. A., Sprenkle, P. C., Bahler, C., Box, G., Carlsson, S. V., Catalona, W. J., Dahl, D. M., Dall’Era, M., Davis, J. W., Drake, B. F., Epstein, J. I., Etzioni, R. B., Farrington, T. A., Garraway, I. P., Jarrard, D., Kauffman, E., Kaye, D., Kibel, A. S., LaGrange, C. A., . . . Freedman-Cass, D. A. (2023). NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 21(3), 236-246. https://doi.org/10.6004/jnccn.2023.0014 Nayan, M., Carvalho, F. L. F., & Feldman, A. S. (2022). Active surveillance for intermediate-risk prostate cancer. World J Urol, 40(1), 79-86. https://doi.org/10.1007/s00345-021-03893-1 NCCN. (2022). NCCN Guidelines for Patients: Early Prostate Cancer. https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf Nilsson, R., Næss-Andresen, T. F., Myklebust, T., Bernklev, T., Kersten, H., & Haug, E. S. (2021). Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance. Eur Urol Open Sci, 25, 44-51. https://doi.org/10.1016/j.euros.2021.01.002 Parker, P. A., Davis, J. W., Latini, D. M., Baum, G., Wang, X., Ward, J. F., Kuban, D., Frank, S. J., Lee, A. K., Logothetis, C. J., & Kim, J. (2016). Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int, 117(3), 469-477. https://doi.org/10.1111/bju.13099 Paterson, C., Kata, S. G., Nandwani, G., Das Chaudhury, D., & Nabi, G. (2017). Unmet Supportive Care Needs of Men With Locally Advanced and Metastatic Prostate Cancer on Hormonal Treatment: A Mixed Methods Study. Cancer Nurs, 40(6), 497-507. https://doi.org/10.1097/ncc.0000000000000482 Paterson, C., Robertson, A., Smith, A., & Nabi, G. (2015). Identifying the unmet supportive care needs of men living with and beyond prostate cancer: A systematic review. Eur J Oncol Nurs, 19(4), 405-418. https://doi.org/10.1016/j.ejon.2014.12.007 Prashar, J., Schartau, P., & Murray, E. (2022). Supportive care needs of men with prostate cancer: A systematic review update. Eur J Cancer Care (Engl), 31(2), e13541. https://doi.org/10.1111/ecc.13541 Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J., & Peña, B. M. (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res, 11(6), 319-326. https://doi.org/10.1038/sj.ijir.3900472 Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997). The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 49(6), 822-830. https://doi.org/10.1016/s0090-4295(97)00238-0 Speakman, M., Kirby, R., Doyle, S., & Ioannou, C. (2015). Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int, 115(4), 508-519. https://doi.org/10.1111/bju.12745 Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71(3), 209-249. https://doi.org/10.3322/caac.21660 Sypre, D., Pignot, G., Touzani, R., Marino, P., Walz, J., Rybikowski, S., Maubon, T., Branger, N., Salem, N., Mancini, J., Gravis, G., Bendiane, M. K., & Bouhnik, A. D. (2022). Impact of active surveillance for prostate cancer on the risk of depression and anxiety. Sci Rep, 12(1), 12889. https://doi.org/10.1038/s41598-022-17224-w Tan, H. J., Marks, L. S., Hoyt, M. A., Kwan, L., Filson, C. P., Macairan, M., Lieu, P., Litwin, M. S., & Stanton, A. L. (2016). The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer. J Urol, 195(6), 1724-1730. https://doi.org/10.1016/j.juro.2016.01.108 Taylor, K. L., Luta, G., Hoffman, R. M., Davis, K. M., Lobo, T., Zhou, Y., Leimpeter, A., Shan, J., Jensen, R. E., Aaronson, D. S., & Van Den Eeden, S. K. (2018). Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study. Transl Behav Med, 8(2), 156-165. https://doi.org/10.1093/tbm/ibx005 Tewari, A. K., Whelan, P., & Graham, J. (2014). Prostate cancer : diagnosis and clinical management. John Wiley & Sons, Ltd. Tosoian, J. J., & Carter, H. B. (2016). Active Surveillance of Localized Prostate Cancer: Acknowledging Uncertainty. J Clin Oncol, 34(36), 4452. https://doi.org/10.1200/jco.2016.67.8888 Utomo, E., Blok, B. F., Pastoor, H., Bangma, C. H., & Korfage, I. J. (2015). The measurement properties of the five-item International Index of Erectile Function (IIEF-5): a Dutch validation study. Andrology, 3(6), 1154-1159. https://doi.org/10.1111/andr.12112 Venderbos, L. D. F., Aluwini, S., Roobol, M. J., Bokhorst, L. P., Oomens, E., Bangma, C. H., & Korfage, I. J. (2017). Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer. Qual Life Res, 26(6), 1635-1645. https://doi.org/10.1007/s11136-017-1507-7 Violette, P. D., Agoritsas, T., Alexander, P., Riikonen, J., Santti, H., Agarwal, A., Bhatnagar, N., Dahm, P., Montori, V., Guyatt, G. H., & Tikkinen, K. A. (2015). Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis. CA Cancer J Clin, 65(3), 239-251. https://doi.org/10.3322/caac.21272 Wade, J., Rosario, D. J., Macefield, R. C., Avery, K. N., Salter, C. E., Goodwin, M. L., Blazeby, J. M., Lane, J. A., Metcalfe, C., Neal, D. E., Hamdy, F. C., & Donovan, J. L. (2013). Psychological impact of prostate biopsy: physical symptoms, anxiety, and depression. J Clin Oncol, 31(33), 4235-4241. https://doi.org/10.1200/jco.2012.45.4801 Walker, C. H., Marchetti, K. A., Singhal, U., & Morgan, T. M. (2022). Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes. World J Urol, 40(1), 35-42. https://doi.org/10.1007/s00345-021-03622-8 Watson, E., Shinkins, B., Frith, E., Neal, D., Hamdy, F., Walter, F., Weller, D., Wilkinson, C., Faithfull, S., Wolstenholme, J., Sooriakumaran, P., Kastner, C., Campbell, C., Neal, R., Butcher, H., Matthews, M., Perera, R., & Rose, P. (2016). Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. BJU Int, 117(6b), E10-19. https://doi.org/10.1111/bju.13122 Watts, S., Leydon, G., Eyles, C., Moore, C. M., Richardson, A., Birch, B., Prescott, P., Powell, C., & Lewith, G. (2015). A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance. BMJ open, 5(5), e006674. https://doi.org/10.1136/bmjopen-2014-006674 Wong, C. K., Choi, E. P., Chan, S. W., Tsu, J. H., Fan, C. W., Chu, P. S., Cheung, F. K., Ma, W. K., Mah, I. S. F., Yip, S. K., Hou, S. S., So, H. S., & Lam, C. K. (2017). Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia. Aging Male, 20(4), 241-249. https://doi.org/10.1080/13685538.2017.1362380 Yang, Y., Ding, R., Hu, D., Zhang, F., & Sheng, L. (2014). Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients. Compr Psychiatry, 55(1), 215-220. https://doi.org/10.1016/j.comppsych.2013.08.012 Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatr Scand, 67(6), 361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90407 | - |
| dc.description.abstract | 攝護腺癌是全球男性常見的癌症之一，通常疾病進展速度較慢，會採用積極監測(Active Surveillance, AS)作為治療方式。故本研究目的為(1)探討積極監測型攝護腺癌病人之害怕疾病進展及照護需求，(2)探討病人照護需求之相關因素，(3)探討影響照護需求之重要預測因子。
本研究為橫斷性研究，於台灣北部某醫學中心之泌尿科門診進行收案，研究個案為採取積極監測型之攝護腺癌病人，以結構式量表進行訪談，包含評估整體照護需求調查、害怕疾病進展、焦慮、憂鬱、攝護腺症狀、勃起功能及人口學特性，本研究取得倫理試驗委員會同意後開始進行資料收集，由已受訓之研究助護理師協助病人逐題進行填答，資料以描述性及推論性統計進行分析。 本研究收集102位個案並完成資料分析，研究結果顯示個案整體身體功能良好，五大層面之整體照護需求由高至低分別為：(1)健康系統與資訊需求、(2)心理需求、(3)病患照顧與支持需求、(4)性需求、(5)生理與日常生活需求，平均分數及標準差依排序為36.4(28.4)、31.6(25.9)、18.3(22.8)、13(24.8)、13(18.9)。害怕疾病進展、焦慮、憂鬱、較短積極監測時間、攝護腺症狀與整體照護需求及各五大層面大部分呈現低度至中度相關，疲倦及害怕疾病進展為影響整體照護需求之最有力預測因子。 本研究結果將提供積極監測型攝護腺癌病人照護需求相關之實證依據，有助於臨床醫護人員了解、評估此類型病人之需求及後續影響，並從而發展出相關之照護及介入措施。 | zh_TW |
| dc.description.abstract | Background Prostate cancer is one of the most common cancers in men worldwide. Because the disease usually progresses slowly, active surveillance (AS) is used as a treatment method. Therefore, the purpose of this study is (1) to explore the fear of disease progression and care needs in patients with active surveillance prostate cancer, (2) to explore the related factors of patients' care needs.(3) to explore the robust factors impact care needs.
Method This study is a cross-sectional study. Cases were accepted in the urology clinic of a medical center in northern Taiwan. The subjects were prostate cancer patients with active surveillance. Interviews were conducted with structured scales, including surveys to assess overall care needs, fear of disease progression, anxiety, depression, prostatic symptoms, erectile function, and demographic characteristics. This study began to collect data after obtaining the approval of the ethics trial committee. In particular, trained study nurses assisted patients to complete questionnaires. The data were analyzed descriptively and correlatively. Results This study collected 102 cases and completed the data analysis. The results of the study show that the overall physical function of the cases is good. The five domains of supportive care need were ranked (1) health system and information needs, (2) psychological needs, (3) patient care and support needs, (4) sexuality needs, (5) physiological and daily living needs, the average scores and standard deviations are 36.4 (28.4), 31.6 (25.9), 18.3 (22.8), 13 (24.8), 13 (18.9). Fear of disease progression, anxiety, depression, shorter active surveillance time, prostate symptoms revealed low to moderate correlations in most of the five domains and overall supportive care needs. Fatigue and fear of disease progression are the robust factors impact care needs among prostate patients on active surveillance. Conclusion The results of this study will provide an empirical basis for the care needs of patients with active surveillance prostate cancer. They also help clinical medical staff understanding and evaluating the needs and subsequent impact of this type of patients and developing relevant care and intervention measures. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-28T16:15:31Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2023-09-28T16:15:31Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii 英文摘要 iv 第一章 緒論 1 第一節 研究背景及重要性 1 第二節 研究目的 2 第二章 文獻查證 3 第一節 攝護腺腫瘤與其治療簡介 3 第二節 攝護腺癌病人之照護需求 10 第三節 照護需求之相關因素 13 第三章 研究方法 16 第一節 研究設計 16 第二節 研究架構與操作型定義 17 第三節 研究假設 19 第四節 研究工具 20 第五節 研究流程及倫理考量 25 第六節 資料建立及分析 27 第四章 研究結果 28 第一節 人口學特性及疾病相關特性 28 第二節 照護需求現況 29 第三節 心理及生理層面 30 第四節 照護需求與自變項之相關性及差異分析 32 第五節 整體照護需求之主要預測因子 34 第五章 討論 35 第一節 個人屬性及疾病特性對照護需求影響 35 第二節 疾病症狀因素與整體照護需求相關性 36 第三節 病人心理衝擊對照護需求影響 37 第四節 整體照護需求預測因子 39 第六章 結論與建議 40 參考資料 42 | - |
| dc.language.iso | zh_TW | - |
| dc.subject | 害怕疾病進展 | zh_TW |
| dc.subject | 攝護腺癌 | zh_TW |
| dc.subject | 積極監測 | zh_TW |
| dc.subject | 照護需求 | zh_TW |
| dc.subject | 焦慮 | zh_TW |
| dc.subject | Fear of Progression | en |
| dc.subject | Prostate Cancer | en |
| dc.subject | Anxiety | en |
| dc.subject | Care Needs | en |
| dc.subject | Active Surveillance | en |
| dc.title | 積極監測型攝護腺癌病人之害怕疾病進展及照護需求探討 | zh_TW |
| dc.title | Fear of Progression and Care Needs in Prostate Cancer Patients on Active Surveillance | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 111-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 蒲永孝;李芸湘 | zh_TW |
| dc.contributor.oralexamcommittee | Yeong-Shiau Pu;Yun-Hsiang Lee | en |
| dc.subject.keyword | 攝護腺癌,積極監測,照護需求,害怕疾病進展,焦慮, | zh_TW |
| dc.subject.keyword | Prostate Cancer,Active Surveillance,Care Needs,Fear of Progression,Anxiety, | en |
| dc.relation.page | 62 | - |
| dc.identifier.doi | 10.6342/NTU202303694 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2023-08-09 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 護理學研究所 | - |
| dc.date.embargo-lift | 2025-08-08 | - |
| 顯示於系所單位： | 護理學系所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-111-2.pdf 授權僅限NTU校內IP使用（校園外請利用VPN校外連線服務） | 1.35 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。